M. Samson
Inserm(FR)Université de Bourgogne(FR)Centre Hospitalier Universitaire Dijon Bourgogne(FR)Clinical Trial Investigators(US)Maison des Sciences sociales et des Humanités de Dijon(FR)Maison des Sciences de l’Homme de Dijon(FR)University of Florence(IT)Université de franche-comté(FR)
Publications by Year
Research Areas
Vasculitis and related conditions, Systemic Lupus Erythematosus Research, Eosinophilic Disorders and Syndromes, Atherosclerosis and Cardiovascular Diseases, Sarcoidosis and Beryllium Toxicity Research
Most-Cited Works
- → Pathogenesis of immune thrombocytopenia(2017)356 cited
- → Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis(2012)344 cited
- → Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)(2018)327 cited
- → Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients(2017)241 cited
- → Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) enrolled in two prospective trials(2013)222 cited
- → Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)